Interaction of heparin with two synthetic peptides that neutralize the anticoagulant activity of heparin

被引:26
|
作者
Wang, Jing [1 ]
Rabenstein, Dallas L. [1 ]
机构
[1] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA
关键词
D O I
10.1021/bi061346a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two synthetic analogues of the heparin-binding domain of heparin/heparan sulfate-interacting protein (Ac-SRGKAKVKAKVKDQTK-NH2) and the all-D-amino acid version of the same peptide (L-HIPAP and D-HIPAP, respectively) were synthesized, and their efficacy as agents for neutralization of the anticoagulant activity of heparin was assayed. The two analogue peptides were found to be equally effective for neutralization of the anticoagulant activity of heparin, as measured by restoration of the activity of serine protease factor Xa by the Coatest heparin method. The finding that L-HIPAP and D-HIPAP are equally effective suggests that D-amino acid peptides show promise as proteolytically stable therapeutic agents for neutralization of the anticoagulant activity of heparin. The interaction of L-HIPAP and D-HIPAP with heparin was characterized by H-1 NMR, isothermal titration calorimetry (ITC), and heparin affinity chromatography. The two peptides were found to interact identically with heparin. Analysis of the dependence of heparin-peptide binding constants on Na+ concentration by counterion condensation theory indicates that, on average, 2.35 Na+ ions are displaced from heparin per peptide molecule bound and one peptide molecule binds per hexasaccharide segment of heparin. The analysis also indicates that both ionic and nonionic interactions contribute to the binding constant, with the ionic contribution decreasing as the Na+ concentration increases.
引用
收藏
页码:15740 / 15747
页数:8
相关论文
共 50 条
  • [1] Characterization of the interaction of heparin with peptides that neutralize the anticoagulant acitivity of heparin.
    Rahenstein, DL
    Wang, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U795 - U795
  • [2] Neutralization of heparin anticoagulant activity by synthetic HIP peptides
    Wang, J
    Rabenstein, DL
    BIOPOLYMERS, 2005, 80 (04) : 561 - 561
  • [3] THE ANTICOAGULANT ACTIVITY OF HEPARIN
    FOSTER, AB
    MARTLEW, EF
    STACEY, M
    CHEMISTRY & INDUSTRY, 1953, (34) : 899 - 900
  • [4] Heparin mimetics with anticoagulant activity
    Al Nahain, Abdullah
    Ignjatovic, Vera
    Monagle, Paul
    Tsanaktsidis, John
    Ferro, Vito
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (05) : 1582 - 1613
  • [5] ANTICOAGULANT ACTIVITY OF HEPARIN OCTASACCHARIDE
    OTOTANI, N
    YOSIZAWA, Z
    JOURNAL OF BIOCHEMISTRY, 1981, 90 (05): : 1553 - 1556
  • [6] BIOSYNTHESIS OF HEPARIN PROTEOGLYCAN AND THE FUNCTIONAL DOMAINS FOR ANTICOAGULANT ACTIVITY OF HEPARIN
    YOSIZAWA, Z
    OTOTANI, N
    SEIKAGAKU, 1982, 54 (06): : 379 - 385
  • [7] Synthetic heparin derivatives as new anticoagulant drugs
    de Kort, M
    Buijsman, RC
    van Boeckel, CAA
    DRUG DISCOVERY TODAY, 2005, 10 (11) : 769 - 779
  • [8] Bioengineered human heparin with anticoagulant activity
    Lord, Megan S.
    Cheng, Bill
    Tang, Fengying
    Lyons, J. Guy
    Rnjak-Kovacina, Jelena
    Whitelock, John M.
    METABOLIC ENGINEERING, 2016, 38 : 105 - 114
  • [9] ANTICOAGULANT ACTIVITY OF HEPARIN IN INTRAVENOUS FLUIDS
    OKUNO, T
    NELSON, CA
    JOURNAL OF CLINICAL PATHOLOGY, 1975, 28 (06) : 494 - 497
  • [10] HEPARIN AND CONCANAVALIN-A INTERACTION AS A MODEL FOR STUDYING THE MECHANISM OF THE ANTICOAGULANT ACTIVITY
    MONGE, JC
    RECONDO, EF
    DERECONDO, MEF
    THROMBOSIS RESEARCH, 1989, 54 (03) : 237 - 243